Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots

Area of Science:

• Genetics
• Neuroscience
• Developmental Biology

Background:

• Rett syndrome (RTT) is a neurodevelopmental disorder affecting infant girls, characterized by skill loss after normal development.
• The methyl-CpG binding protein 2 (MECP2) gene has been identified as the cause of RTT.

Purpose of the Study:

• To investigate the spectrum of phenotypes associated with mutations in the MECP2 gene.
• To explore the relationship between different MECP2 mutations and their clinical manifestations.

Main Methods:

• Analysis of MECP2 gene mutations, including nonsense and missense variants.
• Identification of nucleotide substitutions and deletions at critical functional domains of MeCP2.
• Correlation of specific mutations with observed clinical phenotypes in affected individuals.

Main Results:

• Identified recurrent nonsense (R168X, R255X) and missense (R106W, R306C) MECP2 mutations.
• Found de novo missense mutations affecting conserved MeCP2 domains, often involving C-->T transitions at CpG hotspots.
• Observed a broader phenotypic spectrum, including RTT, incontinentia pigmenti, motor coordination issues, learning disabilities, and congenital encephalopathy, linked to various MECP2 mutations.

Conclusions:

• MECP2 mutations are not exclusively linked to Rett syndrome and are implicated in a wider range of neurodevelopmental disorders.
• Some males with MECP2 mutations may survive to birth, and female carriers with skewed X-inactivation may exhibit milder symptoms.
• Understanding the full phenotypic spectrum of MECP2 mutations is crucial for accurate diagnosis and genetic counseling.